Grant activities
Grant activities
KCRI successfully obtains grants for research and development projects in clinical science
Grant activities
Besides providing quality research services for our industry clients, we are also committed to being an active participant in, and contributor to advancing clinical science and innovative product and process development.
To that end, KCRI has an ongoing in-house initiative to seek research and development funding opportunities from Polish, European, and other international sources and match them with our interest and expertise, as well as with those of our Partners’. We apply and participate as the main grant recipient or as a partner in multi-institution consortia or as a subcontractor.
We are an active participant in projects under Polish, European, and international Programmes.
Project No. PMT/0556/4N/2019
Project No. PMT/0556/4N/2019 under the Smart Growth Operational Program 2014-2020, Priority axis III “Support for innovation in enterprises”, Measure 3.3 “ Support for promotion and internationalization of innovative enterprises”, Sub-measure 3.3.1 “Polish tech Bridge”.
Co-financing of the project from the EU: 200 000,00 PLN
The company participated in the implementation of the project to expand into the Israeli market, using for these purposes consultation of local experts, information and promotion activities and participation in industry conferences, trade and exhibition events.
EuroPCR 2018 in Paris
KCRI in collaboration with Klaster LifeScience Kraków on 6-8 November 2017 took part in BioEurope 2017 in Berlin as the part of “PROmocja potencjału gospodarczego BIORegionu MAŁOPOLSKA na arenie międzynarodowej (ProBio Małopolska)” project implementation.
BIO-Europe is an annual event being the largest biotechnology partnering conference held in Europe. Over 3,800 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward.
Smart Growth Operational Program 2014-2020, Priority axis III “Support for innovation in enterprises”
KCRI in collaboration with Klaster LifeScience Kraków on 6-8 November 2017 took part in BioEurope 2017 in Berlin as the part of “PROmocja potencjału gospodarczego BIORegionu MAŁOPOLSKA na arenie międzynarodowej (ProBio Małopolska)” project implementation.
BIO-Europe is an annual event being the largest biotechnology partnering conference held in Europe. Over 3,800 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward.
Integrated device system for transcatheter closure of paraVAlvular LEaks (VALE)”
KCRI in collaboration with Klaster LifeScience Kraków on 6-8 November 2017 took part in BioEurope 2017 in Berlin as the part of “PROmocja potencjału gospodarczego BIORegionu MAŁOPOLSKA na arenie międzynarodowej (ProBio Małopolska)” project implementation.
BIO-Europe is an annual event being the largest biotechnology partnering conference held in Europe. Over 3,800 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward.
KCRI in collaboration with Klaster LifeScience Kraków on 6-8 November 2017 took part in BioEurope 2017 in Berlin as the part of “PROmocja potencjału gospodarczego BIORegionu MAŁOPOLSKA na arenie międzynarodowej (ProBio Małopolska)” project implementation.
BIO-Europe is an annual event being the largest biotechnology partnering conference held in Europe. Over 3,800 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward.
Project “WROVASC – Integrated Cardiovascular Center
BIO-Europe is an annual event being the largest biotechnology partnering conference held in Europe. Over 3,800 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward.
Project Initiatives
KCRI plays also an important role as a project initiator both, as consortia partner and a project facilitator:
01. KCRI as a consortia partner
KCRI is interested in participation in national and international consortia for health and technological R&D and innovation projects.
02. KCRI as a project facilitator
If you have an interesting R&D project in health or technology field and think KCRI could be a suitable partner, KCRI can help you in project conceptualization, development and submission.
Investigator sponsored and initiated research
- Are you a physician and investigator?
- Do you have an interesting clinical research idea?
- Do you plan a research grant with clinical study?
KCRI helps to translate your idea into a trial project assuring proper quality and compliance with ICH-GCP guidelines and regulatory standards.Our company was started by physicians and researchers – no one will understand your problems and needs better.
Treatment strategy comparisons, interesting concepts from individual investigators, niche applications, and unmet clinical needs require professional support and research infrastructure. One of KCRI’s goals is to enable and support these activities.
